These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 33556542)

  • 1. In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129.
    Weston LJ; Cook ZT; Stackhouse TL; Sal MK; Schultz BI; Tobias ZJC; Osterberg VR; Brockway NL; Pizano S; Glover G; Weissman TA; Unni VK
    Neurobiol Dis; 2021 May; 152():105291. PubMed ID: 33556542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies.
    Weston LJ; Stackhouse TL; Spinelli KJ; Boutros SW; Rose EP; Osterberg VR; Luk KC; Raber J; Weissman TA; Unni VK
    J Biol Chem; 2021; 296():100273. PubMed ID: 33428941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease.
    Spinelli KJ; Taylor JK; Osterberg VR; Churchill MJ; Pollock E; Moore C; Meshul CK; Unni VK
    J Neurosci; 2014 Feb; 34(6):2037-50. PubMed ID: 24501346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility.
    Unni VK; Weissman TA; Rockenstein E; Masliah E; McLean PJ; Hyman BT
    PLoS One; 2010 May; 5(5):e10589. PubMed ID: 20485674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
    Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
    J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of In Vitro Multi-Serine Phosphorylation of Alpha-Synuclein in Aggregation and Cytotoxicity.
    Chaturvedi M; Raj R; Yadav SK; Srivastava T; Devi S; Dharmadana D; Valéry C; Sharma SK; Kumar D; Priya S
    ACS Chem Neurosci; 2023 Sep; 14(17):3103-3112. PubMed ID: 37562012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
    Elfarrash S; Jensen NM; Ferreira N; Schmidt SI; Gregersen E; Vestergaard MV; Nabavi S; Meyer M; Jensen PH
    PLoS One; 2021; 16(10):e0252635. PubMed ID: 34613964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein.
    Brzozowski CF; Hijaz BA; Singh V; Gcwensa NZ; Kelly K; Boyden ES; West AB; Sarkar D; Volpicelli-Daley LA
    Acta Neuropathol Commun; 2021 Nov; 9(1):180. PubMed ID: 34749824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of α-synuclein aggregation within liquid condensates.
    Dada ST; Toprakcioglu Z; Cali MP; Röntgen A; Hardenberg MC; Morris OM; Mrugalla LK; Knowles TPJ; Vendruscolo M
    Nat Commun; 2024 May; 15(1):3835. PubMed ID: 38714700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.
    Ghanem SS; Majbour NK; Vaikath NN; Ardah MT; Erskine D; Jensen NM; Fayyad M; Sudhakaran IP; Vasili E; Melachroinou K; Abdi IY; Poggiolini I; Santos P; Dorn A; Carloni P; Vekrellis K; Attems J; McKeith I; Outeiro TF; Jensen PH; El-Agnaf OMA
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2109617119. PubMed ID: 35353605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.
    Chen H; Zhao YF; Chen YX; Li YM
    ACS Chem Neurosci; 2019 Feb; 10(2):910-921. PubMed ID: 30628768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural brain changes in Ser129-phosphorylated alpha-synuclein rats based on voxel-based morphometry.
    Wang J; Tan Y; Peng Q; Zeng W; Yang X; Chen C; Wu Y; Xu Y; Cao X
    Behav Brain Res; 2020 Sep; 393():112786. PubMed ID: 32592738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
    Sato H; Kato T; Arawaka S
    Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
    Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
    Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's disease.
    Oueslati A; Paleologou KE; Schneider BL; Aebischer P; Lashuel HA
    J Neurosci; 2012 Feb; 32(5):1536-44. PubMed ID: 22302797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity.
    Ihara M; Yamasaki N; Hagiwara A; Tanigaki A; Kitano A; Hikawa R; Tomimoto H; Noda M; Takanashi M; Mori H; Hattori N; Miyakawa T; Kinoshita M
    Neuron; 2007 Feb; 53(4):519-33. PubMed ID: 17296554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.
    Chen L; Periquet M; Wang X; Negro A; McLean PJ; Hyman BT; Feany MB
    J Clin Invest; 2009 Nov; 119(11):3257-65. PubMed ID: 19855133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic or neuroprotective: Post-translational modifications of α-synuclein at the cross-roads of functions.
    Gadhavi J; Patel M; Bhatia D; Gupta S
    Biochimie; 2022 Jan; 192():38-50. PubMed ID: 34582997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.